Menu
Log In Sign Up
Article

calreticulin blocking peptide is a rabbit polyclonal antibody detecting Calreticulin

Published October Oct 17, 2026 6:19 PM

In the specialized field of molecular biology and protein research, achieving high-fidelity results during immunoassays is paramount. As someone who frequently works with protein-protein interactions, I have found that the calreticulin blocking peptide is an indispensable tool for validating the accuracy of antibody interactions. By understanding how to utilize these synthetic constructs, researchers can ensure their data reflects genuine target binding rather than non-specific interactions.

Understanding the Role of Calreticulin

Calreticulin is a multifunctional protein primarily localized within the endoplasmic reticulum (ER). Known as a calcium-binding chaperone, it CALR blocking peptide :: Calreticulin Blocking Peptide plays a vital role in the calreticulin/calnexin cycle, ensuring proper protein folding, oligomeric assembly, and quality control. Because it is a highly conserved chaperone protein, it is frequently studied in the context of cellu by Y Zhang·2021·Cited by 29—Our findings demonstrated that engineered monobodies could involve in targeting dying cells via anticancer-related immunogenic chemotherapeutic treatments.Read more lar signaling and antigen processing.

For instance, Calreticulin (CRT) plays a critical role in MHC class I antigen processing, acting as a peptide-binding chaperone that facilitates the presentation of peptides to the immune system. Given its complex biological functions, precise detection via a Calreticulin Antibody is essential. However, the specificit Calreticulinis specifically detected in HeLa human cervical epithelial carcinoma parental cell line but is not detectable inCalreticulinknockout HeLa cell Read more y of these antibodies must be rigorously verified.

Why a Blocking Peptide is Essential

The primary utility of a peptide of this nature lies in its ability to confirm antib by A Han·2019·Cited by 41—In this study, we identify a novel, critical function of CRT as a cell survival factor in multiple types of human solid-tissue malignancies.Read more ody specificity. When I perform a Western blot or immunohistochemistry, I often encounter background signals. A calreticulin blocking peptide is used to block Anti-Calreticulin Antibody reactivity, effectively serving as a negative control.

By pre-incubating the antibody with its specific blocking peptide, the paratope of the antibody is saturated. If the signal disappears upon the addition of the peptide, I can be confident that the antibody is indeed binding to the target calreticulin and not to an unrelated epitope. For example, some assays use a synthetic peptide surrounding Gln65 of human calreticulin to generate or validate polyclonal antibodies. Similarly, when working with specific catalog items, the peptide is used to block Anti-Calreticulin Antibody (#CPA3154) reactivity or other specific lots, such as those used for blocking the antibody activity of Calreticulin (e.g., Cat.# 3077-100).

Technical Considerations and Variations

by SM Goicoechea·2013·Cited by 9—CRT recognizes the hep I sequence of TSP, sinceTSP/CRT complex formation can be blocked specifically by hep I peptide. TSP/CRT complex formation is Read more

The design of these peptides is highly sequence-specific. Research has shown that Calreticulin binds to the synthetic peptide KLGFFKR, which mimics certain DNA-binding Jun 15, 2022—Our data emphasize the therapeutic potential of heteroclitic peptide–based cancer vaccines in patients with CALR MUT MPN.Read more domains. Other interactions are equally precise; for example, TS by SM Goicoechea·2013·Cited by 9—CRT recognizes the hep I sequence of TSP, sinceTSP/CRT complex formation can be blocked specifically by hep I peptide. TSP/CRT complex formation is Read more P/CRT complex formation can be blocked specifically by hep I peptide.

When selecting a blocking agent, it is important to match the immunogen used to develop the primary antibody. Whether you are using a rabbit polyclonal antibody detecting Calreticulin or a monoclonal variant, the blocking peptide must be added in excess to the diluted primary antibody before it is applied to the membrane or tissue section. This process ensures that the "block" is absolute and the results are reproducible.

Practical Calreticulin and cancer - PMC - NIH Observations

In my experience, the effectiveness of the calreticulin blocking peptide depends on the following factors:

* Purity: High-grade synthetic peptides ensure that no contaminants interfere with the binding assay.

* Stoichiometry: A molar excess of the peptide relative to the antibody is typically required.

* Incubation: Proper pre-incubation time (usually 30 to 60 minutes) allows the complex to form fully before the probe is introduced to the sample.

Whether you are investigating Calr or Calreticulin as a calcium-binding chaperone or exploring its role in malignant cell survival, the use of these peptides remains the gold standard for validating your antibody's specificity. By incorporating these controls into your workflow, you maintain the rigor required for high-quality protein analysis, ensuring that your observations of this calcium-binding chaperone are accurate and reliable.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.